Welcome to Specialised Therapeutics

SE Asia (HQ)
+65 3158 9940
Australia

1300 798 820
New Zealand
+64 9801 0299

Home
About
Products
Pipeline
Partnering
News and Resources
Orders
Contact us

Home
About
Products
Pipeline
Partnering
News and Resources
Orders
Contact us

May 2015 - AKYNZEO^® Acquired

Share on Facebook Share on Twitter Share on LinkedIn Share on Tumblr Pin this Share on VK Email this

ST acquires AKYNZEO® (netupitant) under exclusive license from Helsinn Healthcare

Next article

Previous article

With the highest professional and ethical standards, we commercialise therapies and technologies that uniquely fulfil the unmet needs of our community.

Quick Links

Home
About
Products
Pipeline
News & Resources
Orders
Contact us

Latest News

Specialised Therapeutics Signs Exclusive Agreement with Ascendis Pharma A/S for Distribution and Commercialisation of Three Endocrinology Therapies in Australia and Select South-East Asia Countries

January 8, 2024

Specialised Therapeutics Signs Exclusive License Agreement with CanariaBio for New Ovarian Cancer Therapy

October 13, 2023

Follow Us

Privacy Policy | Terms and Conditions | Site Map | Copyright © 2021 Specialised Therapeutics